U.S., Feb. 27 -- ClinicalTrials.gov registry received information related to the study (NCT06848166) titled 'Study of the Effectiveness and Safety of Embolization of the Middle Meningeal Artery Using Non-adhesive Materials SQUID 12 and SQUID 18 in the Treatment of Patients with Chronic Resistant Migraine' on Feb. 21.
Brief Summary: To evaluate the effectiveness and safety of middle meningeal artery (MMA) embolization using non-adhesive materials SQUID 12 and SQUID 18 as a treatment method for patients with chronic resistant migraine.
Study Start Date: Oct. 25, 2024
Study Type: INTERVENTIONAL
Condition:
Chronic Migraine Headache
Intervention:
DEVICE: liquid embolic agent SQUID 12, liquid embolic agent SQUID 18
Total endovascular embo...